AtriCure gets 510(k) clearance for AtriClip device

Shares of West Chester, OH-based AtriCure soared on news that the FDA approved the company's AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion System, a device which blocks blood clots during heart procedures. AtriClip could bring in up to $300 million a year for the company. Story